NASDAQ: ALNY · Health Care / Biotechnology: Pharmaceutical Preparations

Alnylam Pharmaceuticals Inc.

How Alnylam Pharmaceuticals Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$23.3B

Price

$174.00

P/E

8.8

EPS (TTM)

$19.79

1-year return

-61.3%

Dividend yield

0.0%

52-week range

$174.00–$473.29

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector
• NASDAQ-100

For information only, not investment advice. Data may contain errors. Disclaimer · Sources